State Street SPDR S&P Pha... (XPH)
NYSEArca: XPH
· Precio en tiempo real · USD
70.42
-0.56 (-0.79%)
Al cierre: Aug 17, 2026, 3:57 PM
State Street SPDR S&P Pharmaceuticals ETF (XPH) ETF Price, Holdings & Analysis
-0.79% (1D)
| Precio de compra | 0 |
| Capitalización de mercado | n/a |
| AUM | 489.39M |
| NAV | 70.91 |
| Beta | 0.7 |
| EPS (ttm) | n/a |
| Relación PE (ttm) | 18.62 |
| Acciones en circulación | 5.5M |
| Fecha de inicio | Jun 19, 2006 |
| Precio de venta | 0 |
| Volumen | 86,879 |
| Volumen medio (20D) | 97,278 |
| Abierto | 70.03 |
| Cierre anterior | 70.98 |
| Rango del día | 69.66 - 70.72 |
| Rango de 52 semanas | 45.80 - 71.13 |
| Participaciones | n/a |
| Relación de gastos | 0.35% |
Acerca de XPH
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
Clase de activo Equity
Símbolo bursátil XPH
Fecha de inicio Jun 19, 2006
Proveedor State Street Investment Management
Sitio web Página de inicio del fondo
Intercambio NYSEArca
Las 10 principales participaciones 25.66% de activos
| Nombre | Símbolo | Peso |
|---|---|---|
| Crinetics Pharmaceut... | CRNX | 3.69% |
| Mbx Biosciences Inc | MBX | 3.22% |
| Ataibeckley Inc | ATAI | 2.88% |
| Definium Therapeutic... | DFTX | 2.84% |
| Amylyx Pharmaceutica... | AMLX | 2.29% |
| Enliven Therapeutics... | ELVN | 2.24% |
| Corcept Therapeutics... | CORT | 2.22% |
| Alumis Inc | ALMS | 2.13% |
| Nuvation Bio Inc Ord... | NUVB | 2.09% |
| Trevi Therapeutics I... | TRVI | 2.06% |
Dividendos Rendimiento de dividendos 0.48%
| Ex-Dividendo | Cantidad | Fecha de pago |
|---|---|---|
| Jun 22, 2026 | $0.0590 | n/a |
| Mar 23, 2026 | $0.0610 | n/a |
| Dec 22, 2025 | $0.1130 | n/a |
| Sep 22, 2025 | $0.1030 | n/a |
| Jun 23, 2025 | $0.0960 | n/a |
Página 1 de 2